PTAB denies Celltrion’s patent challenge against Genentech

07-03-2017

PTAB denies Celltrion’s patent challenge against Genentech

Duncan_Andison / iStockphoto.com

The Patent Trial and Appeal Board (PTAB) has rejected Celltrion’s challenge against a Genentech patent centring on a method of treating rheumatoid arthritis, stating that the challenged patent did not show any reasonable likelihood of being invalid.


PTAB, USPTO, Celltrion, patent, IPR, Genentech

LSIPR